| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | — | — | — | — | — | — | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2024 | ‡‡‡ |
|
| 2023 | ‡‡‡ |
|
| 2022 | ‡‡‡ |
|
| 2021 | ‡‡‡ |
|
| 2022 | 2023 | 2024 | Q'25 | |
|---|---|---|---|---|
| Cash | 0.82 | 1.06 | 13.70 | 22.45 |
| Receivables | — | 0.08 | 5.36 | 4.94 |
| Inventory | — | — | — | — |
| Other | 0.59 | — | 2.06 | 2.70 |
| 1.41 | 1.87 | 23.59 | 31.31 |
| 2022 | 2023 | 2024 | Q'25 | |
|---|---|---|---|---|
| Payables | 0.87 | 1.50 | 5.44 | 3.54 |
| ST’ Debt | 2.24 | — | — | — |
| Other | 1.59 | 0.66 | 0.62 | 0.64 |
| 4.69 | 3.78 | 11.08 | 6.13 |
| 10y | 5y | 3y | |
| Sales | — | — | ‡‡‡‡‡ |
| Cash Flow | — | ‡‡‡ | ‡‡‡ |
| Earnings | — | ‡‡‡ | ‡‡‡ |
| Book Value | — | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 2.77 | — | — | — |
—
|
| ’24 | 0.68 | 4.65 | 8.04 | 6.33 |
19.70
|
| ’23 | 0.02 | 0.04 | — | 0.09 |
0.15
|
| ’20 | — | — | — | 0.10 |
0.10
|
| ’19 | — | — | — | — |
0.50
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (11.01) | — | — | — |
—
|
| ’24 | (2.68) | (6.18) | (2.91) | (6.42) |
(18.18)
|
| ’23 | (4.73) | (3.66) | (3.42) | (4.35) |
(16.16)
|
| ’22 | — | (2.39) | (2.11) | (3.09) |
(11.14)
|
| ’22 | (3.55) | (2.77) | (2.50) | (3.30) |
(11.14)
|
| ’21 | (2.87) | (0.24) | (1.51) | (0.81) |
(6.58)
|
| ’20 | (1.04) | — | — | — |
(1.04)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (12.67) | — | — | — |
—
|
| ’24 | (2.74) | (6.17) | (4.98) | (10.44) |
(24.33)
|
| ’23 | (5.16) | (3.93) | (3.80) | (5.44) |
(18.33)
|
| ’22 | — | (2.64) | (2.13) | (3.56) |
(11.95)
|
| ’22 | (3.62) | (2.82) | (2.96) | (3.30) |
(11.14)
|
| ’21 | (4.45) | (0.24) | (1.54) | (0.81) |
(8.22)
|
| ’20 | (1.07) | — | — | — |
(1.07)
|
| Jun | Sep | Dec | Mar | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | (5.79) |
—
|
| ’24 | (879.10) | (188.06) | — | (2.90k) |
(548.26)
|
| ’23 | (401.43k) | (20.94k) | — | (10.69k) |
(121.63k)
|
| ’22 | (36.08k) | (24.05k) | (12.03k) | — |
(109.58k)
|
| ’22 | (50.78k) | (52.12k) | — | (38.75k) |
(49.45)
|
| ’21 | (1.81) | (0.67) | (0.45) | (253.90k) |
(276.27)
|
| ’20 | — | — | (0.25) | (0.26) |
(63.88)
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | 67,503.71 | 2,612.25 | 18.30 | — | — | — |
Low Price
|
| — | — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | 5,251,654.00 | 810,044.56 | 13,500.01 | — | — | — |
High Price
|
| — | — | — | — | — | ‡‡‡‡ | ‡‡‡‡ | 16 | 12 | 65 | — | — | — |
Employees
|
| — | — | — | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | 0.00 | 0.01 | 0.30 | — | — | — |
Revenue/Emp
|
| — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | — | — | 0.15 | 19.70 | — | — | — |
Revenue
|
| — | — | — | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡ | 0.00% | (510.46%) | (3.62%) | — | — | — |
Gross Margin
|
| — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (14.31) | (28.98) | (25.95) | — | — | — |
EBT
|
| — | — | — | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | 0.00% | (18,943.79%) | (131.70%) | — | — | — |
EBT Margin
|
| — | — | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (14.31) | (28.98) | (25.95) | — | — | — |
Net Income
|
| — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.00 | 10.70 | 3.20 | — | — | — |
Depreciation
|
| — | — | — | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | 0.00 | 0.56 | 0.33 | — | — | — |
Revenue/Sh
|
| — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (49.45) | (121,630.70) | (548.26) | — | — | — |
Earnings/Sh
|
| — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (38.33) | (59.40) | (0.31) | — | — | — |
Cash Flow/Sh
|
| — | — | — | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.00 | (7.99) | (0.10) | — | — | — |
Capex/Sh
|
| — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (38.33) | (67.39) | (0.41) | — | — | — |
Free CF/Sh
|
| — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.82 | 17.19 | 0.38 | — | — | — |
Book Value/Sh
|
| — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.29 | 0.27 | 59.22 | — | — | — |
Shares
|
| — | — | — | ‡‡‡ | ‡‡‡ | ‡‡‡ | — | — | 0.00 | 0.00 | — | — | — |
PE Ratio
|
| — | — | — | ‡‡‡ | ‡‡‡ | ‡‡‡ | — | — | 3,691.35 | 64.12 | — | — | — |
PS Ratio
|
| — | — | — | ‡‡‡ | ‡‡‡ | ‡‡‡ | — | — | 199.68 | 56.79 | — | — | — |
PB Ratio
|
| — | — | — | ‡‡‡ | ‡‡‡ | ‡‡‡ | — | — | 3,690.44 | 63.48 | — | — | — |
EV/Sales
|
| — | — | — | ‡‡‡ | ‡‡‡ | ‡‡‡ | — | — | (50.93) | (51.41) | — | — | — |
EV/FCF
|
| — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (11.14) | (16.16) | (18.18) | — | — | — |
Op' Cash Flow
|
| — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.81) | (2.17) | (6.14) | — | — | — |
Capex
|
| — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (11.14) | (18.33) | (24.33) | — | — | — |
FCF
|
| — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (3.28) | (1.91) | 12.51 | — | — | — |
Working Cap'
|
| — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.60 | — | 0.68 | — | — | — |
Total Debt
|
| — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.78 | (1.06) | (13.02) | — | — | — |
Net Debt
|
| — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.53 | 4.68 | 22.24 | — | — | — |
Sh' Equity
|
| — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (176.95%) | (368.06%) | (145.89%) | — | — | — |
ROA
|
| — | — | — | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | 0.00% | (333.54%) | (163.47%) | — | — | — |
ROIC
|
| — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (301.95%) | (1,139.24%) | (241.21%) | — | — | — |
ROE
|
Crown Electrokinetics Corp. (CRKN) is pioneering electrokinetic thin-film technology for smart windows and displays, perfectly timed for the global shift toward energy-efficient buildings that guzzle 40% of world energy. The real fireworks? Revenue exploded from $153,000 in 2023 to $19.7 million in 2024—a mind-blowing 12,769% surge—fueled by production ramps, employee headcount jumping 442%, and revenue per employee soaring 2,278%. This isn’t hype; it’s commercial traction with partnerships in architectural glass, hinting at massive scalability in cleantech.
Despite ongoing losses, CRKN shows clear momentum: EBT losses narrowed 10%, margins improved dramatically (EBT margin from -189% to -1.3%), and efficiency metrics like ROA and ROE turned less negative. Cash position strengthened with positive working capital, low debt, and normalizing valuations (PS ratio down 98% to 64). Dilution hit book value hard, but equity grew 376%, setting a resilient base for inflection.
Analysts see explosive upside—price targets implying over 8 million percent gains from ~25-cent levels—as CRKN eyes $50M+ revenue by 2026, positive margins, and dominance in a $10B+ electrochromics market. With NASA ties, green policy tailwinds, and no insider selling, this disruptor screams “early innings” for patient investors. Dive into the full analysis for the charts and catalysts.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.